LRP11-AS1 promotes the proliferation and migration of triple negative breast cancer cells via the miR-149-3p/NRP2 axis

BACKGROUND: Breast cancer is the most commonly diagnosed cancer in women. Triple negative breast cancer (TNBC) is the most difficult subtype of breast cancer to treat due to the deficiency in drug-targetable receptors. LRP11-AS1, a newly identified oncogenic long noncoding RNA (lncRNA) was found to...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Peng, Zeng, Yu, Chen, Yudan, Huang, Peng, Chen, Xinchun, Zheng, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917722/
https://www.ncbi.nlm.nih.gov/pubmed/35279146
http://dx.doi.org/10.1186/s12935-022-02536-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917722/
https://www.ncbi.nlm.nih.gov/pubmed/35279146
http://dx.doi.org/10.1186/s12935-022-02536-8

Ejemplares similares